Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs SoundHound AI Inc (SOUN) Price & Performance

Medpace Holdings IncTrade
SoundHound AI IncTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs SoundHound AI Inc — how do they compare? Medpace Holdings Inc trades at $597.39 (market cap $16.90B), while SoundHound AI Inc trades at $7.4 (market cap $3.29B). The key difference: Medpace Holdings Inc is far larger — about 5.1× SoundHound AI Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals.

MEDPSOUN
Market Cap
$16.90B$3.29B
Sector
TechnologyTechnology
52-Week High
$620.59$21.40
52-Week Low
$393.42$5.70
Enterprise Value
$16.52B$3.09B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.

MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.

SoundHound AI Inc

SoundHound AI (SOUN) trades at $7.40, down 0.8% on the day, with strong technical momentum indicated by bullish moving averages. The company shows impressive revenue growth of 45% in Q2 2026 and has beaten earnings expectations for three consecutive quarters. Recent news highlights the proposed LivePerson acquisition and the successful launch of the OASYS platform, which is accelerating enterprise adoption and driving improved guidance.

While growth prospects appear promising with 75% analyst buy ratings and an $8.50 consensus target, significant risks remain including persistent negative margins (-67.45% net income margin), high valuation multiples (P/S 15.31), and substantial cash burn. The stock offers growth potential but requires careful risk management given the premium valuation and path to profitability challenges.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP

About SoundHound AI Inc

SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.

Read more on SOUN